BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 10697654)

  • 1. Impact of Time Factors on Outcome in Patients with Head and Neck Cancer Treated with Definitive Radio(Chemo)Therapy.
    Dahlke S; Steinmann D; Christiansen H; Durisin M; Eckardt A; Wegener G; Bremer M; Meyer A
    In Vivo; 2017; 31(5):949-955. PubMed ID: 28882964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of multidisciplinary team management in head and neck cancer patients.
    Friedland PL; Bozic B; Dewar J; Kuan R; Meyer C; Phillips M
    Br J Cancer; 2011 Apr; 104(8):1246-8. PubMed ID: 21448166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-specific Real-World 5-year Overall Survival Rates for (Radio)chemotherapy, Targeted Therapy, and Combinations in Patients With Head and Neck Cancer.
    Baudrexl J; Pietzka S; Scheurer M; Schramm A; Wilde F; Sakkas A; Derka S; Ebeling M
    Anticancer Res; 2024 Jan; 44(1):267-286. PubMed ID: 38159994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comprehensive treatment strategies for head neck tumors].
    Huang Z; Wen W; Mao W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 37(9):673-690. PubMed ID: 37640991
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of malignant rhabdoid tumors of the head and neck with combined chemotherapy and
    Duan C; Zheng L; Zhang D; Jin M; Su Y; Zhao W; Wang X; Zhao Q; Huang C; Zhang J; Zhang J; Ni X; Ma X
    Pediatr Investig; 2018 Mar; 2(1):53-55. PubMed ID: 32851232
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of comorbidity scores and lifestyle factors in curative radiotherapy in laryngeal cancer.
    Pechacova Z; Lohynska R; Pala M; Drbohlavova T; Korinek T
    Strahlenther Onkol; 2023 Oct; 199(10):881-890. PubMed ID: 37042973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant radiotherapy of head and neck carcinoma: an obstacle for plastic reconstruction?
    Riml S; Böhler F; Larcher L; de Vries A; Elsässer W; Kompatscher P
    Wien Klin Wochenschr; 2012 Sep; 124(17-18):599-604. PubMed ID: 22850812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment resistance of solid tumors: role of hypoxia and anemia.
    Vaupel P; Thews O; Hoeckel M
    Med Oncol; 2001; 18(4):243-59. PubMed ID: 11918451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer.
    Morisada M; Chamberlin M; Allen C
    Head Neck; 2018 Jun; 40(6):1321-1334. PubMed ID: 29461655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of radiotherapy in the treatment of metastatic head and neck cancer.
    Ordoñez R; Otero A; Jerez I; Medina JA; Lupiañez-Pérez Y; Gomez-Millan J
    Onco Targets Ther; 2019; 12():677-683. PubMed ID: 30705596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery.
    Wagner W; Hermann R; Hartlapp J; Esser E; Christoph B; Müller MK; Krech R; Koch O
    Strahlenther Onkol; 2000 Feb; 176(2):73-80. PubMed ID: 10697654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors.
    Schäfer U; Micke O; Müller SB; Schüller P; Willich N
    Strahlenther Onkol; 2003 Aug; 179(8):527-34. PubMed ID: 14509951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer].
    Hermann RM; Krech R; Hartlapp J; Esser E; Christoph B; Müller MK; Wagner W
    Strahlenther Onkol; 2001 Jun; 177(6):277-82. PubMed ID: 11446315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
    Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J
    J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.